VALIANT result studies - Novartis.com Search Novartis.com - Go Novartis.com Home Products Diseases & Conditions About Novartis Investor Relations Media Relations Careers Corporate Citizenship Business Development Pharmaceutical Best Sellers Pharmaceuticals CIBA Vision Animal Health Over the Counter Infant and Baby Medical Nutrition Our Mission Our Businesses Leadership & Governance Research & Development Foundations...
Generic Names of Some Trade Name Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs -~ Generic Names of Some Trade Name Drugs - Generic Names of Some...
Some Trade Names of Generic Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs-~ Generic Names of Some Trade Name Drugs - Some Trade Names of...
Index N, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - INDEX - Index-A -~ Index-B -~ Index-C -~ Index-D -~ Index-E -~ Index-F -~ Index-G -~ Index-H -~ Index-I -~ Index-J -~ Index-K -~ Index-L -~ Index-M -~ Index-N-~ Index-O ...
Diabetes Mellitus: Merck Manual Home Edition Section Hormonal Disorders Subject Diabetes Mellitus Diabetes Mellitus Diabetes mellitus is a disorder in which blood sugar (glucose) levels are abnormally high because the body does not produce enough insulin.
Diabetes Mellitus: Merck Manual Home Edition Search Recent Searches Index Sections A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders Cancer Children's Health Issues Digestive Disorders Disorders of Nutrition and Metabolism Drugs Ear, Nose, and Throat Disorders Eye Disorders Fundamentals Heart and Blood Vessel...
Index: NA: Merck Manual Home Edition candidiasis of Candidiasis: Symptoms infection of (onychomycosis) Ringworm Ringworm: Treatment spoon Iron: Symptoms thickening of (onychauxis and onychogryphosis) Onychauxis and Onychogryphosis Naltrexone Alcohol: Detoxification and Rehabilitation Opioids: Detoxification and Rehabilitation Naphazoline Nonprescription Cold Remedies Naproxen Pain Relievers: Over-the Counter Versus...
Meglitinides for type 2 diabetes - [Medication] - Quest Diagnostics Patient Health Library Meglitinides for type 2 diabetes Examples Brand Name Chemical Name Prandin repaglinide Starlix nateglinide Nateglinide (Starlix) and repaglinide (Prandin) help stop the rapid rise in blood sugar levels that can occur immediately after a person with type 2 diabetes eats.
PDF cover 0433.qxd DOLPHIN Current Patents Gazette Patenting in Context News & Highlights from Week 0433 The records appearing in this Gazette will be added to DOLPHIN, the database Of all pharmaceutical inventions in the next week.
author: LEmson
Novartis launch largest diabetes prevention trial to date - - - - BioNews BioWeb Companies Products BioReports - - - - - - PRESS RELEASE released on 10 Sept.Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research) trial aims to determine whether long-term administration of nateglinide (Starlix ® ) or valsartan (Diovan ® ), to people who have IGT and are at high cardiovascular risk,...
Novartis Press Kit English page 11
author: guestnc1
duplicates:http://www.novartis.com/downloads/press_kit.pdf
Database S S - investigational drugs, therapies and vaccines # - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z From this page you may order documents with information covering investigational products.
http://www.adis.com/files/newsletters/INP/Icov1429.pdf 20 Antipsychotics (atypical, long- acting): guidelines on use 3 Statins: intensive dosage regimen preferable 15 Escitalopram continuation prevents depression relapse 15 New British guidelines simplify hypertension treatment 4 Modafinil improved energy levels in chronic fatigue syndrome 16 Olanzapine/ risperidone not for use in elderly with dementia 21 ENDOCRINOLOGY Paroxetine: UK CSM...
Contents Vol. 43, No. 4, 2004 4, 2004 Contents Leading Article Pharmacokinetic Considerations in Development of a 211- 225 Bioartificial Liver H Iwata, Y Ueda Review Articles Comparative Pharmacokinetics and Pharmacodynamics of 227- 238 Short- Acting Hypnosedatives: Zaleplon, Zolpidem and Zopiclone DR Drover Clinical Pharmacokinetics of Quinupristin/ Dalfopristin 239- 252 DT Bearden Original Research Population...
author: Adis International Limited
subject: Clinical Pharmacokinetics
Contents Vol. 43, No. 2, 2004 2, 2004 Contents Leading Article Antiepileptic- Induced Resistance to Neuromuscular 71- 81 Blockers: Mechanisms and Clinical Significance SG Soriano, JA Jeevendra Martyn Review Articles Clinical Pharmacokinetics of Everolimus 83- 95 GI Kirchner, I Meier- Wiedenbach, MP Manns Clinical Pharmacokinetics of Nateglinide: A Rapidly- 97- 120 Absorbed, Short- Acting Insulinotropic...
author: Adis International Limited
subject: Clinical Pharmacokinetics
Approved Active Moieties to which FDA has issued a Written Request for Pediatric Studies under Section 505A of the Federal Approved Active Moieties to which FDA has issued a Written Request for Pediatric Studies under Section 505A of the Federal Food, Drug, and Cosmetic Act NOTE: This list simply identifies approved active moieties to which FDA has issued a Written Request for pediatric studies since June 1998
http://www.fda.gov/cder/orange/appendix_a.txt 2, BUTABARBITAL SODIUM SARISOL, BUTABARBITAL SODIUM APPENDIX A PRODUCT NAME INDEX SATRIC, METRONIDAZOLE SCABENE, LINDANE SCANDONEST L, LEVONORDEFRIN SCANDONEST PLAIN, MEPIVACAINE HYDROCHLORIDE SCLEROSOL, TALC SCRUBTEAM SURGICAL SPONGEBRUSH, HEXACHLOROPHENE SEASONALE, ETHINYL ESTRADIOL SECOBARBITAL SODIUM, SECOBARBITAL SODIUM SECONAL SODIUM, SECOBARBITAL SODIUM SECREFLO, SECRETIN...
EFFICACY SUPPLEMENTS APPROVED IN CALENDAR YEAR 2003 FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - - EFFICACY SUPPLEMENTS APPROVED IN CALENDAR YEAR 2003 (SE1 -SE7)* and EFFICACY SUPPLEMENTS APPROVED IN CALENDAR YEAR 2003 (SE8)* - GENERIC NAME APPLICANT NDA NUMBER SUPP TYPE SUPP NUMBER RECEIPT DATE APPROVAL DATE PRIORITY REVIEW TOTAL APPROVAL TIME (MONTHS) INDICATION/DESCRIPTION FLUOXETINE...
http://www.novartis.com/downloads_new/news/product_snapshot_english.pdf Novartis Pharmaceutical Products 2004 A Snapshot This brochure is not meant for US residents.
duplicates:http://www.novartis.com/downloads_new/news/product_snapshot_english.pdf
http://www.novartis.com/downloads_new/news/product_snapshot_english.pdf page 23
duplicates:http://www.novartis.com/downloads_new/news/product_snapshot_english.pdf
http://www.novartis.com/downloads_new/news/product_snapshot_english.pdf page 6
duplicates:http://www.novartis.com/downloads_new/news/product_snapshot_english.pdf
21-204_Starlix (Nateglinide) Tablets Food and Drug Administration • Center for Drug Evaluation and Research Approval Package Search Starlix (Nateglinide) Tablets Company:--Novartis Pharmaceuticals Corporation Application No.:--21-204 Approval Date:-12/22/2000 - Approval Letter(s) - Printed Labeling - Medical Review(s)- Part 1 - Part 2 - Chemistry Review(s) - Pharmacology Review(s)- Part 1 - Part 2 -...
author: Paul Stauffer
http://www.adis.com/files/newsletters/AIT/Aicov59.pdf 12 Pneumococcal conjugate vaccine holds great promise 6 Posaconazole for difficult- to- treat coccidioidomycosis 7 Adverse Reaction Case Reports Pseudomonas vaccine induces immune response 6 Antiretrovirals: fatal lactic acidosis [S] 13 T- cell replacement therapy for post- transplant CMV infection 7 Cefuroxime: immune haemolysis [S] 13 Didanosine/ metformin/ stavudine: fatal lactic...
http://www.adis.com/files/newsletters/INP/Icov1410.pdf 15 Corticosteroids: patient concerns may affect use in RA 17 CARDIO/ VASCULAR Etoricoxib effective in chronic low back pain 11 Candesartan cilexetil: effects in hypertension + obesity 16 Oxycodone/ naltrexone may attenuate osteoarthritic pain 6 Hydrochlorothiazide: effects in hypertension + obesity 16 NEUROLOGY JNK inhibitor protects against cerebral ischaemia 6 NSAIDs may prevent or...
Report to the Nation: Drug Review Priority new drug approvals (N=NME) Abacavir/lamivudine/zidovudine (Trizivir) Alosetron (Lotronex) (N) Arsenic trioxide (Trisenox) (N) Atovaquone/proquanil (Malarone) Bexarotene (Targetin) Budesonide (Pulmicort) Didanosine (Videx EC) Gentuzumab ozogamicin (Mylotarg) (N) Levobetaxolol (Betaxon) Levofloxacin (Quixin) Linezolid (Zyvox) (3 NDAs approved, 1 as NME) (N) Lopinavir/ritonavir...
author: OLIVERN
